piwik-script

Intern
    Chair for Drug Formulation and Delivery

    News-Archiv

    Johanna Siehler won the Otto Bayer Fellowship and becomes fellow of the organization. The program is supporting her intended stay at our partner lab at Columbia University, NY (Dr. Gordana Vunjak-Novakovic). Congratulations to this success!

    Mehr

    Synthesis of bioactive and clickable BMP-2 variants! Congratulations to Eva, Tessa, Christoph R. and Lorenz for co-authoring a manuscript about in vitro performances of genetically engineered bone morphogenetic protein 2 (BMP-2) for site-specific immobilization, together with our colleagues Thomas D. Müller and Joachim Nickel. We are looking forward to future clinical studies of site-directed decorated BMP-2 scaffolds!

    Mehr

    Vom 25.10.2015 bis 28.10.2015 besuchten uns Delegationen der Universitäten von Soochow und der Zhejiang Universität. Mit beiden hat die Universität ein gemeinsames Forschungsprojekt mit dem Titel „Macrophage Plasticity Deployed for Efficient Bone (Re-)generation“ (GZ 1094).

    Mehr

    From 23rd to 30th of October the Institute of Pharmacy is hosting guests from China, who are part of a binational research consortium between our Institute, Soochow University and Zheijiang University. The research focus is on the development of biomaterials, controlling macrophage plasticity as a modality to induce musculoskeletal tissue (re-)generation.

    Mehr

    Congratulations to Vera Werner!!! She successfully completed her Ph.D. with her defense as of August 5, 2015.

    Mehr

    Site specific labeling of biologics is important to further improve the quality of drug-biologic conjugates. Tessa Lühmann and her team have addressed this challenge for FGF-2 - a potent anabolic growth factor – by introducing unnatural amino acids into FGF-2 through genetic engineering. Thereby, non-natural functional groups are introduced into the biologic thereby allowing site specific decoration. Congratulations to this successful and inspiring contribution!

    Mehr

    Ionic liquids typically result from melting point depression of API salts as compared to akin salts with small counterions. Although this depression may positively drive pharmaceutical parameters including the dissolution rate or solubility some caveats apply. Anja Balk and colleagues discuss the “pro et contra” of using ionic liquid approaches for pharmaceutical application.

    Mehr
    2017
    2015
    2011

    Hinweis zum Datenschutz

    Mit 'OK' verlassen Sie die Seiten der Universität Würzburg und werden zu Facebook weitergeleitet. Informationen zu den dort erfassten Daten und deren Verarbeitung finden Sie in deren Datenschutzerklärung.

    Hinweis zum Datenschutz

    Mit 'OK' verlassen Sie die Seiten der Universität Würzburg und werden zu Twitter weitergeleitet. Informationen zu den dort erfassten Daten und deren Verarbeitung finden Sie in deren Datenschutzerklärung.

    Kontakt

    Lehrstuhl für Pharmazeutische Technologie und Biopharmazie
    Am Hubland
    97074 Würzburg

    Tel.: +49 931 31-85470
    E-Mail

    Suche Ansprechpartner

    Hubland Süd, Geb. C7
    Hubland Süd, Geb. C7